ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
Q4 2025 earnings call recap: revenue growth, 2026 guidance, margins, sales force expansion & reimbursement risks—read key insights now.
He shot to fame playing the titular character in "Dawson's Creek" and in later years mocked his own hunky persona.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する